Similar Items: Total free lipids from MDR strain of Mycobacterium tuberculosis “M” reduce T cell activation and CTL activity in healthy individuals
- Mycobacterial MCE proteins as transporters that control lipid homeostasis of the cell wall
- IFNG-mediated immune responses enhance autophagy against Mycobacterium tuberculosis antigens in patients with active tuberculosis
- In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
- Mycobacterium tuberculosis infection in a free‑ranging urban dog from Argentina
- Polymorphisms of 20 regulatory proteins between Mycobacterium tuberculosis and Mycobacterium bovis
- B cell and antibody responses in bovine tuberculosis
Author: Bigi, María Mercedes
- Total free lipids from MDR strain of Mycobacterium tuberculosis “M” reduce T cell activation and CTL activity in healthy individuals
- A transcriptional analysis of cattle immune cells reveals a central role of type 1 interferon in the In vitro innate immune response against Mycobacterium bovis
- B cell and antibody responses in bovine tuberculosis
- Production of functional bovine IL-22 in a mammalian episomal expression system
- Long-term evaluation in BALBc mice of a triple mutant of Mycobacterium bovis and the Bacillus Calmette-Guérin as potential vaccines against bovine tuberculosis
- Characterization of the two component regulatory system PhoPR in Mycobacterium bovis
Author: Imperiale, Belen Rocio
- Total free lipids from MDR strain of Mycobacterium tuberculosis “M” reduce T cell activation and CTL activity in healthy individuals
- In vitro and ex vivo activity of the fluoroquinolone DC-159a against mycobacteria
- Surveillance and characterization of drug‑resistant mycobacterium tuberculosis isolated in a reference hospital from Argentina during 8 years’ period
- Genetic diversity of Mycobacterium avium complex strains isolated in Argentina by MIRU-VNTR
- Relevancia clínica, diversidad y variabilidad genética de distintas especies del género Mycobacterium
- In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates